USANA Health Sciences, Inc.
USNA
$30.02
$0.521.76%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 249.54M | 213.61M | 200.22M | 212.87M | 227.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 249.54M | 213.61M | 200.22M | 212.87M | 227.80M |
| Cost of Revenue | 52.45M | 38.55M | 39.26M | 40.33M | 43.07M |
| Gross Profit | 197.09M | 175.06M | 160.96M | 172.54M | 184.73M |
| SG&A Expenses | 181.42M | 166.85M | 145.36M | 154.70M | 160.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 233.87M | 205.40M | 184.62M | 195.03M | 203.13M |
| Operating Income | 15.67M | 8.21M | 15.60M | 17.84M | 24.67M |
| Income Before Tax | 16.74M | 10.43M | 18.61M | 20.20M | 27.11M |
| Income Tax Expenses | 7.45M | 5.95M | 8.00M | 9.77M | 10.57M |
| Earnings from Continuing Operations | 9.29M | 4.48M | 10.61M | 10.43M | 16.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 112.00K | -30.00K | -- | -- | -- |
| Net Income | 9.40M | 4.45M | 10.61M | 10.43M | 16.54M |
| EBIT | 15.67M | 8.21M | 15.60M | 17.84M | 24.67M |
| EBITDA | 24.01M | 12.21M | 19.17M | 21.65M | 27.83M |
| EPS Basic | 0.49 | 0.23 | 0.56 | 0.55 | 0.86 |
| Normalized Basic EPS | 0.56 | 0.34 | 0.61 | 0.66 | 0.88 |
| EPS Diluted | 0.49 | 0.23 | 0.56 | 0.54 | 0.86 |
| Normalized Diluted EPS | 0.55 | 0.34 | 0.61 | 0.66 | 0.88 |
| Average Basic Shares Outstanding | 19.05M | 19.10M | 19.08M | 19.07M | 19.17M |
| Average Diluted Shares Outstanding | 19.09M | 19.10M | 19.08M | 19.16M | 19.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |